Download Read the UPMC St. Margaret Cancer Program 2013

200 Delafield Road, Pittsburgh, PA 15215
2013
UPMC ST. MARGARET
CANCER PROGRAM:
SUMMARY REPORT
Part of the UPMC CancerCenter
Published December 2013
Accredited by the American College of Surgeons Commission on Cancer
as a Comprehensive Community Cancer Program with commendation
and Outstanding Achievement Award
UPMC CancerCenter at UPMC St. Margaret is dedicated to providing
excellent, state-of-the-art oncology care in the community setting.
We believe that a multidisciplinary team approach provides the best in
patient care. Weekly patient-centered cancer conferences and regular
communication between specialty services and primary care physicians
assures that our patients receive comprehensive cancer care.
UPMC St. Margaret’s dedication to excellent cancer treatment is recognized
by the accrediting body for cancer programs, the American College of
Surgeons Commission on Cancer (COC). The program received the
Outstanding Achievement Award for the last two accreditation periods.
The Cancer Registry department collects data on all new cases of cancer
diagnosed and treated at UPMC St. Margaret for submission to the National
Cancer Data Base (NCDB) and the Pennsylvania Cancer Registry (PCR).
Case reporting to these databases provides a wealth of information about
risk factors, incidence, and treatment effectiveness, and it helps guide
developments in cancer prevention, detection, and treatment.
In this report, UPMC St. Margaret uses our most recently available data,
as well as previous years’ data when necessary to compare our findings
with the latest available from the NCDB.
FIGURE
01
AGE AT DIAGNOSIS OF BREAST CANCER
UPMC St. Margaret vs. NCDB-Comprehensive Community
Cancer Programs (2000-2011)
30
25
20
15
Percent
10
5
0
30-39
40-49
50-59
60-69
70-79
80-89
90+
UPMC SMH
2
12
22
25
23
15
2
NCDB
4
18
25
24
19
9
1
This year’s report focuses on breast cancer. Figure 1 compares patients’ age
at diagnosis at UPMC St. Margaret with the NCDB. At UPMC St. Margaret,
65 percent of those diagnosed are at least 60 years old, compared to 53 percent
nationally. In addition, at UPMC St. Margaret 50 percent are 70 or older.
FIGURE
02
BREAST CANCER: AJCC STAGE AT DIAGNOSIS
UPMC St. Margaret vs. NCDB-Comprehensive Community
Cancer Programs (2011)
Percent
of patients
50
45
40
35
30
25
20
15
10
5
0
Stage at Diagnosis
3
4
UNK
STAGE
0
1
2
UPMC St. Margaret
18
45
23
8
5
1
NCDB
20
42
24
8
4
2
Evaluation of the amount and spread of cancer is referred to as the stage of
disease. Stage, pathologic and molecular data, and patient-specific factors help
determine the best treatment regimen for the individual patient. Generally,
the lower the stage of disease, the greater the likelihood of successful treatment.
Figure 2 shows that for diagnosis year 2011 (the last full year available),
UPMC St. Margaret is in keeping with the national trend toward diagnosing breast
cancer at an earlier stage: stages 0, 1, and 2. Both UPMC St. Margaret and the
NCDB show that 86 percent of patients were diagnosed at these earlier stages.
Survival statistics are based on deaths from all causes, not just deaths from
breast cancer.
FIGURE
03
BREAST CANCER: SURVIVAL BY AJCC STAGE
UPMC St. Margaret vs. National Cancer Data Base (2003-2006)
Percent
of patients
surviving
Stage
100
90
80
70
60
50
40
30
20
10
0
1
2
3
4
UPMC SMH
87
86
56
24
NCDB
92
85
66
21
Figure 3 compares UPMC St. Margaret patient survival by stage of disease
at diagnosis to the NCDB database. The last year of statistics available from the
NCDB is 2006. In most cases UPMC St. Margaret’s statistics are comparable
to national rates. The lower stage 1 and 3 survival rates can be explained by the
significantly higher age at diagnosis for UPMC St. Margaret patients: 50 percent
of our patients were age 70 or over at diagnosis, compared to the NCDB rate of
29 percent. Since survival statistics include death from all causes, it is likely that
many of these patient died as a result of some other medical condition.
FIGURE
04
BREAST CANCER: NATIONAL STANDARDS
UPMC St. Margaret vs. National Data (2009-2011)
SELECT BREAST MEASURES
ESTIMATED
PERFORMANCE RATES
2009
2010
2011
Radiation therapy is administered within one
year (365 days) of diagnosis for women under
age 70 receiving breast conserving surgery
for breast cancer. [BCS/RT]
100%
100%
100%
Combination chemotherapy is considered or
administered within four months (120 days)
of diagnosis for women under age 70 with
AJCCT1c N0 M0, or Stage II or III ERA and
PRA negative breast cancer. [MAC]
100%
100%
100%
Tamoxifen or third generation aromatase
inhibitor is considered or administered within
one year (365 days) of diagnosis for women
with AJCCT1c N0 M0, or Stage II or III ERA
and/or PRA positive breast cancer. [HT]
100%
100%
100%
Figure 4 shows that the UPMC St. Margaret program treated patients according
to the following national standards 100 percent of the time over the last three
years for which data is available.
The Commission on Cancer and other national cancer specialty organizations
determine standards that all accredited programs are to meet to ensure
appropriate treatment. The Cancer Program Practice Profile Report is updated
yearly and records how well each program meets these important patient
treatment standards.
Our oncology team understands the importance of providing the most advanced
prevention, detection, treatment, and support services to meet the cancer care
needs of our community.